Aitia

Aitia is a forward-thinking biotech firm that utilizes Causal AI, Multi-Omics data, and Gemini Digital Twins to pioneer the next wave of groundbreaking pharmaceuticals. Established in 2019 or earlier, Aitia aims to become a leader in AI-driven biotechnology, expediting the creation and advancement of essential therapeutics that significantly improve patient outcomes. By uncovering the intricate biological processes underlying diseases through causal AI and comprehensive multi-omic patient data, Aitia and its Gemini Digital Twins provide invaluable insights into drug development.

Research & Insights